Oncology
PACLIENT 300
Injection — 300mg/50 ml
WHO-GMP
Product Overview
Paclitaxel Injection USP 300 mg/50 mL is a potent antineoplastic (anticancer) medication that belongs to the taxane family of chemotherapeutic agents.
Indications
Paclitaxel Injection USP 300 mg/50mL is a chemotherapy medication indicated for treating ovarian, breast, lung, and AIDS-related Kaposi's sarcoma, either as a single agent or in combination therapies.
Dosage Forms & Strength
Available Forms
Injection
Strength
300mg/50 ml
Regulatory Approvals
WHO-GMP